Healthpeak Properties (NYSE:DOC) Downgraded by StockNews.com

StockNews.com downgraded shares of Healthpeak Properties (NYSE:DOC) from a hold rating to a sell rating in a report published on Tuesday.

A number of other analysts have also recently weighed in on the stock. Evercore ISI boosted their target price on shares of Healthpeak Properties from $25.00 to $26.00 and gave the stock an outperform rating in a research note on Monday. Royal Bank of Canada raised their price objective on Healthpeak Properties from $22.00 to $25.00 and gave the company an outperform rating in a report on Tuesday, July 30th. Citigroup upped their target price on Healthpeak Properties from $20.00 to $22.00 and gave the stock a neutral rating in a report on Thursday, August 22nd. Wedbush lifted their price target on Healthpeak Properties from $22.00 to $25.00 and gave the company an outperform rating in a research note on Monday, July 29th. Finally, Scotiabank boosted their price target on Healthpeak Properties from $23.00 to $24.00 and gave the stock a sector outperform rating in a report on Monday, September 9th. One research analyst has rated the stock with a sell rating, five have given a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of Moderate Buy and a consensus target price of $21.83.

Healthpeak Properties Stock Performance

NYSE:DOC opened at $21.90 on Tuesday. Healthpeak Properties has a twelve month low of $15.24 and a twelve month high of $22.79. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.91. The stock’s 50-day simple moving average is $21.72 and its 200 day simple moving average is $19.84. The firm has a market capitalization of $15.41 billion, a PE ratio of 62.57, a price-to-earnings-growth ratio of 2.31 and a beta of 1.14.

Healthpeak Properties (NYSE:DOC) last posted its earnings results on Thursday, July 25th. The real estate investment trust reported $0.21 EPS for the quarter, missing analysts’ consensus estimates of $0.44 by ($0.23). The company had revenue of $695.50 million during the quarter, compared to the consensus estimate of $665.11 million. Healthpeak Properties had a return on equity of 3.51% and a net margin of 11.93%. The firm’s revenue was up 27.5% compared to the same quarter last year. During the same period last year, the company posted $0.45 EPS. On average, analysts anticipate that Healthpeak Properties will post 1.8 EPS for the current fiscal year.

Healthpeak Properties Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, August 16th. Investors of record on Monday, August 5th were paid a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 5.48%. The ex-dividend date was Monday, August 5th. Healthpeak Properties’s dividend payout ratio is currently 342.86%.

Institutional Investors Weigh In On Healthpeak Properties

A number of institutional investors have recently modified their holdings of the company. Norges Bank acquired a new position in shares of Healthpeak Properties in the 4th quarter valued at about $34,883,000. Vanguard Personalized Indexing Management LLC acquired a new position in Healthpeak Properties in the fourth quarter valued at approximately $892,000. APG Asset Management US Inc. bought a new position in shares of Healthpeak Properties during the 4th quarter worth approximately $1,450,000. Gillson Capital LP acquired a new stake in shares of Healthpeak Properties during the 4th quarter worth approximately $1,261,000. Finally, Cibc World Markets Corp bought a new stake in shares of Healthpeak Properties in the 4th quarter valued at $1,066,000. 93.57% of the stock is owned by institutional investors.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.